home / stock / cort / cort news

CORT News and Press, Corcept Therapeutics Incorporated From 02/19/26

Stock Information
Company Name: Corcept Therapeutics Incorporated
Stock Symbol: CORT
Market: NASDAQ
Website: corcept.com
Menu
Get CORT Alerts

News, Short Squeeze, Breakout and More Instantly...
CORT - US Companies Moving the Markets, Evening edition
Thu, Feb 19, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.4% to $1.7852 on volume of 510,359,702 shares Interactive Strength Inc. (TRNR) rose 19.3% to $0.488 on volume of 290,201,967 shares Theriva Biologics, Inc. (TOVX) rose 9.1% to $0...
CORT - Corcept falls as appeals court sides with Teva in Korlym patent dispute

2026-02-19 11:10:48 ET More on Corcept Therapeutics Why Corcept Therapeutics' Relacorilant Fell Short And What It Means For The Company Corcept: Korlym Defies Generics As Relacorilant Hits An FDA CRL (Rating Upgrade) Corcept Therapeutics: Despite FDA Blind Side, Rela...

CORT - CORT ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations

NEW YORK, NY - February 19, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...

CORT - CORCEPT THERAPEUTICS ALERT: Corcept Therapeutics, Inc. (CORT) are Encouraged to Contact Kaplan Fox Regarding Potential Securities Law Violations

NEW YORK, NY - February 18, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...
CORT - Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2025 financial results and provide a corporate update on February 24, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). ...

CORT - CORT SECURITIES INVESTIGATION: Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

NEW YORK, NY - February 17, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...

CORT - CORT ALERT: Ongoing Investigation Into Corcept Therapeutics Incorporated - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. Wh...
CORT - CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

NEW YORK, NY - February 14, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...

CORT - CORT INVESTIGATION REMINDER: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

NEW YORK, NY - February 13, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...

CORT - CORT SECURITIES INVESTIGATION: Kaplan Fox is Investigating Possible Securities Violations Against Corcept Therapeutics, Inc. (CORT)

NEW YORK, NY - February 7, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT TH...
Previous 10 Next 10